Hanmi Science

008930 · KOSPI · Financials · LARGE CAP

Back to a net profit.

Hanmi Science filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$236M (+3.7% year on year), operating profit of US$25.8M (+197.4% year on year) and net income of US$21.3M (from a loss a year earlier).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-02-05· RCEPT 20260205800820

US$236MRevenue
+3.7%Revenue vs a year earlier
US$25.8MOperating profit

Converted at 1 USD ≈ ₩1,460.11 (filing-date rate, 2026-02-05 close)

What happened

Hanmi Science filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$236M (+3.7% year on year), operating profit of US$25.8M (+197.4% year on year) and net income of US$21.3M (from a loss a year earlier).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$236M
Revenue vs a year earlier+3.7%
Operating profitUS$25.8M
Net incomeUS$21.3M
PeriodQ4 2025 (consolidated)
Filed2026-02-05, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260205800820 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-05 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.